Wide coverage of Alzheimer s drug Leqembi would raise future costs for Medicare by at least $2 billion a year, according to a study led by University of California researchers.
/PRNewswire/ The "Novel Antibody Therapies Market: Distribution by Type of Novel Antibody, Target Indication, Type of Therapy, Route of Administration, and.
DUBLIN (BUSINESS WIRE) The "Novel Antibody Therapies Market: Distribution by Type of Novel Antibody, Target Indication, Type of Therapy, Route of Administration, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035" report has been added to ResearchAndMarkets.com's offering.The 'Novel Anti.